These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26983295)

  • 1. Biomarkers and personalized cancer medicine.
    Alers NI
    MLO Med Lab Obs; 2016 Feb; 48(2):18. PubMed ID: 26983295
    [No Abstract]   [Full Text] [Related]  

  • 2. Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back.
    Chau NG; Lorch JH
    Oncologist; 2015 Jul; 20(7):699-701. PubMed ID: 26040619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
    Horlings HM; Shah SP; Huntsman DG
    JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
    [No Abstract]   [Full Text] [Related]  

  • 4. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer biomarkers and personalized cancer medicine.
    Dou XL; Bai CM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Feb; 37(1):113-7. PubMed ID: 25676280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized treatment for patients with colorectal cancer: role of biomarkers.
    Duffy MJ
    Biomark Med; 2015; 9(4):337-47. PubMed ID: 25808438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Companion diagnostic testing for targeted cancer therapies: an overview.
    Fan YS
    Genet Test Mol Biomarkers; 2013 Jul; 17(7):515-23. PubMed ID: 23574530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present and future of personalized medicine in adult genitourinary tumors.
    Ciccarese C; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Conti A; Tortora G; Cascinu S; Montironi R
    Future Oncol; 2015; 11(9):1381-8. PubMed ID: 25952784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical issues and advances in cancer precision medicine research.
    Nasution MD; Wang X
    J Biopharm Stat; 2018; 28(2):215-216. PubMed ID: 29513634
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway Analysis.
    Wu T; Wang X; Li J; Song X; Wang Y; Wang Y; Zhang L; Li Z; Tian J
    PLoS One; 2015; 10(6):e0131183. PubMed ID: 26126114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Medicine for Personalized Cancer Therapy.
    Wong AH; Deng CX
    Int J Biol Sci; 2015; 11(12):1410-2. PubMed ID: 26681920
    [No Abstract]   [Full Text] [Related]  

  • 13. Personalized Devices Predict Cancer Drug Sensitivity In Vivo.
    Balakrishnan VS
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26340999
    [No Abstract]   [Full Text] [Related]  

  • 14. Of art and science: is personalized medicine getting personal enough?
    Hendlisz A
    Curr Opin Oncol; 2015 Jul; 27(4):349-50. PubMed ID: 26049276
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Diagnostic and Predictive Biomarkers 2015.
    Buonaguro FM; Pauza CD; Tornesello ML; Hainaut P; Franco R
    Biomed Res Int; 2015; 2015():235985. PubMed ID: 26543851
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of biomarkers and personalized cancer therapeutics. Abstracts of the 4th WIN Symposium. June 28-29, 2012. Paris, France.
    Ann Oncol; 2012 Jun; 23 Suppl 5():v6-43. PubMed ID: 22774229
    [No Abstract]   [Full Text] [Related]  

  • 17. Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomes.
    Martin JH; Phillips E; Thomas D; Somogyi AA
    Br J Clin Pharmacol; 2015 Nov; 80(5):929-31. PubMed ID: 26507561
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticipating designer drug-resistant cancer cells.
    Frangione ML; Lockhart JH; Morton DT; Pava LM; Blanck G
    Drug Discov Today; 2015 Jul; 20(7):790-3. PubMed ID: 25697478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free DNA as a novel marker in cancer therapy.
    Kato S; Janku F
    Biomark Med; 2015; 9(7):703-12. PubMed ID: 26174844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.